Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

FDA approves IVAX drug for IC

Oct. 4, 1996

Glaxo Wellcome reports new diuretics

Oct. 4, 1996

Yamanouchi reports agent for urinary incontinence

Sep. 27, 1996

NC-1800 advances through clinical trials

Sep. 20, 1996

New agents for BPH from Abbott

Sep. 20, 1996

Merck & Co. continues to investigate 5alpha-reductase inhibitors

Sep. 20, 1996

Development of VML-252 progresses

Sep. 13, 1996

Cimetidine for treatment of interstitial cystitis

Sep. 6, 1996

Darifenacin for urge incontinence

Sep. 6, 1996

Potential use for YM-934 in bladder hypersensitivity

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 6, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.